Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression

Anna Testa, Francesco Lotti, Linda Cairns, Alexis Grande, Sergio Ottolenghi, Giuliana Ferrari, Antonella Ronchi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The locus control region of the β-globin gene cluster has been used previously to direct erythroid expression of globin genes from retroviral vectors for the purpose of gene therapy. Short erythroid regulatory elements represent a potentially valuable alternative to the locus control region. Among them, the GATA-1 enhancer HS2 was used to replace the retroviral enhancer within the 3′-long terminal repeat (LTR) of the retroviral vector SFCM, converting it into an erythroid-specific regulatory element. In this work, we have functionally studied an additional GATA-1 enhancer, HS1. HS1 participates in the transcriptional autoregulation of GATA-1 through an essential GATA-binding site that is footprinted in vivo. In this work we identified within HS1 a new in vivo footprinted region, and we showed that this sequence indeed binds a nuclear protein in vitro. Addition of HS1 to HS2 within the LTR of SFCM significantly improves the expression of a reporter gene. The deletion of the newly identified footprinted sequence in the retroviral construct further increases expression up to a level almost equal to that of the wild type retroviral LTR, without loss of erythroid specificity, suggesting that this sequence may act as a negative regulatory element. An improved vector backbone, MAN, allows even better expression from the new GATA cassette. These results suggest that substantial improvement of overall expression can be achieved by the combination of multiple changes in both regulatory elements and vectors.

Original languageEnglish
Pages (from-to)10523-10531
Number of pages9
JournalJournal of Biological Chemistry
Volume279
Issue number11
DOIs
Publication statusPublished - Mar 12 2004

Fingerprint

Terminal Repeat Sequences
Locus Control Region
Globins
Genes
Multigene Family
Nuclear Proteins
Reporter Genes
Gene therapy
Genetic Therapy
Homeostasis
Binding Sites
Gene Expression

ASJC Scopus subject areas

  • Biochemistry

Cite this

Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression. / Testa, Anna; Lotti, Francesco; Cairns, Linda; Grande, Alexis; Ottolenghi, Sergio; Ferrari, Giuliana; Ronchi, Antonella.

In: Journal of Biological Chemistry, Vol. 279, No. 11, 12.03.2004, p. 10523-10531.

Research output: Contribution to journalArticle

Testa, Anna ; Lotti, Francesco ; Cairns, Linda ; Grande, Alexis ; Ottolenghi, Sergio ; Ferrari, Giuliana ; Ronchi, Antonella. / Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 11. pp. 10523-10531.
@article{849a56852b2e4cefb000fbc7b0b410a3,
title = "Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression",
abstract = "The locus control region of the β-globin gene cluster has been used previously to direct erythroid expression of globin genes from retroviral vectors for the purpose of gene therapy. Short erythroid regulatory elements represent a potentially valuable alternative to the locus control region. Among them, the GATA-1 enhancer HS2 was used to replace the retroviral enhancer within the 3′-long terminal repeat (LTR) of the retroviral vector SFCM, converting it into an erythroid-specific regulatory element. In this work, we have functionally studied an additional GATA-1 enhancer, HS1. HS1 participates in the transcriptional autoregulation of GATA-1 through an essential GATA-binding site that is footprinted in vivo. In this work we identified within HS1 a new in vivo footprinted region, and we showed that this sequence indeed binds a nuclear protein in vitro. Addition of HS1 to HS2 within the LTR of SFCM significantly improves the expression of a reporter gene. The deletion of the newly identified footprinted sequence in the retroviral construct further increases expression up to a level almost equal to that of the wild type retroviral LTR, without loss of erythroid specificity, suggesting that this sequence may act as a negative regulatory element. An improved vector backbone, MAN, allows even better expression from the new GATA cassette. These results suggest that substantial improvement of overall expression can be achieved by the combination of multiple changes in both regulatory elements and vectors.",
author = "Anna Testa and Francesco Lotti and Linda Cairns and Alexis Grande and Sergio Ottolenghi and Giuliana Ferrari and Antonella Ronchi",
year = "2004",
month = "3",
day = "12",
doi = "10.1074/jbc.M313638200",
language = "English",
volume = "279",
pages = "10523--10531",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression

AU - Testa, Anna

AU - Lotti, Francesco

AU - Cairns, Linda

AU - Grande, Alexis

AU - Ottolenghi, Sergio

AU - Ferrari, Giuliana

AU - Ronchi, Antonella

PY - 2004/3/12

Y1 - 2004/3/12

N2 - The locus control region of the β-globin gene cluster has been used previously to direct erythroid expression of globin genes from retroviral vectors for the purpose of gene therapy. Short erythroid regulatory elements represent a potentially valuable alternative to the locus control region. Among them, the GATA-1 enhancer HS2 was used to replace the retroviral enhancer within the 3′-long terminal repeat (LTR) of the retroviral vector SFCM, converting it into an erythroid-specific regulatory element. In this work, we have functionally studied an additional GATA-1 enhancer, HS1. HS1 participates in the transcriptional autoregulation of GATA-1 through an essential GATA-binding site that is footprinted in vivo. In this work we identified within HS1 a new in vivo footprinted region, and we showed that this sequence indeed binds a nuclear protein in vitro. Addition of HS1 to HS2 within the LTR of SFCM significantly improves the expression of a reporter gene. The deletion of the newly identified footprinted sequence in the retroviral construct further increases expression up to a level almost equal to that of the wild type retroviral LTR, without loss of erythroid specificity, suggesting that this sequence may act as a negative regulatory element. An improved vector backbone, MAN, allows even better expression from the new GATA cassette. These results suggest that substantial improvement of overall expression can be achieved by the combination of multiple changes in both regulatory elements and vectors.

AB - The locus control region of the β-globin gene cluster has been used previously to direct erythroid expression of globin genes from retroviral vectors for the purpose of gene therapy. Short erythroid regulatory elements represent a potentially valuable alternative to the locus control region. Among them, the GATA-1 enhancer HS2 was used to replace the retroviral enhancer within the 3′-long terminal repeat (LTR) of the retroviral vector SFCM, converting it into an erythroid-specific regulatory element. In this work, we have functionally studied an additional GATA-1 enhancer, HS1. HS1 participates in the transcriptional autoregulation of GATA-1 through an essential GATA-binding site that is footprinted in vivo. In this work we identified within HS1 a new in vivo footprinted region, and we showed that this sequence indeed binds a nuclear protein in vitro. Addition of HS1 to HS2 within the LTR of SFCM significantly improves the expression of a reporter gene. The deletion of the newly identified footprinted sequence in the retroviral construct further increases expression up to a level almost equal to that of the wild type retroviral LTR, without loss of erythroid specificity, suggesting that this sequence may act as a negative regulatory element. An improved vector backbone, MAN, allows even better expression from the new GATA cassette. These results suggest that substantial improvement of overall expression can be achieved by the combination of multiple changes in both regulatory elements and vectors.

UR - http://www.scopus.com/inward/record.url?scp=1642415651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642415651&partnerID=8YFLogxK

U2 - 10.1074/jbc.M313638200

DO - 10.1074/jbc.M313638200

M3 - Article

C2 - 14701820

AN - SCOPUS:1642415651

VL - 279

SP - 10523

EP - 10531

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -